| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/28/2009 | EP2018179A1 Use of antagonists of cxcl13 or cxcr5 for treating wounds or fibrotic diseases |
| 01/28/2009 | EP1470826B1 Decoy-containing pharmaceutical compositions for the treatment of aneurysms |
| 01/28/2009 | EP1435927B1 Use of totarol for the treatment of pruritus |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356152A Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 01/28/2009 | CN101352541A Medicament and preparation method thereof for treating common diseases in home |
| 01/28/2009 | CN101352523A Medicament for treating burn, scald and preparation method thereof |
| 01/28/2009 | CN101352522A Chinese medicine ointment formulation for treating burn and preparation method thereof |
| 01/28/2009 | CN101352521A Onychomycosis medicine and preparation method thereof |
| 01/28/2009 | CN101352516A Safety high-efficient pilatory and preparation method |
| 01/28/2009 | CN101352513A Spot-eliminating beauty treatment composition and preparation thereof |
| 01/28/2009 | CN101352504A Bedsore plaster and method for producing the same |
| 01/28/2009 | CN101352501A Chinese medicine for treating traumatic injury and production method |
| 01/28/2009 | CN101352500A Chinese medicine plaster for treating folliculitis keloidnlis nuchae |
| 01/28/2009 | CN101352497A Chinese medicinal composition for removing chloasma, and preparation method and uses thereof |
| 01/28/2009 | CN101352495A Medicament for treating anal fistula and preparation method thereof |
| 01/28/2009 | CN101352486A Isatis root and astragalus microspheres for injections and preparation method thereof |
| 01/28/2009 | CN101352464A Chinese medicinal composition and preparation method thereof and quality control method |
| 01/28/2009 | CN101352460A Medicament for burn and scald and preparation thereof |
| 01/28/2009 | CN101352450A Prescription of compound external-use ulcer powder |
| 01/28/2009 | CN101352234A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 01/28/2009 | CN100455599C Gene recombinant antibody and its fragment |
| 01/28/2009 | CN100455597C Process of high purity albumin production |
| 01/28/2009 | CN100455568C 6-position substituted indoline, production and use thereof as medicament |
| 01/28/2009 | CN100455324C Externally applied liquid prepn of recombinant human granulocyte-macrophage colony stimulating factor |
| 01/28/2009 | CN100455311C Composition of Chinese traditional medicine in use for treating burn and scald, and product for resolving poxes, and preparation method |
| 01/28/2009 | CN100455307C External medicine for treating dermatosis |
| 01/28/2009 | CN100455287C Formulations |
| 01/28/2009 | CN100455280C An externally applied ointment |
| 01/27/2009 | US7482491 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482383 Emulsion containing a plant extract, method for producing said emulsion and for obtaining said plant extract |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482369 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482362 Substituted-4-quinolones |
| 01/27/2009 | US7482339 Cannabinoid receptor agonists; antipruritic agents, analgesics, bronchodilator agents |
| 01/27/2009 | US7482328 an artificially synthesized antimicrobial polypeptide that does not occur in nature contains in its peptide chain one or more types of nuclear localization signal sequences (NLSs); for drug resistance bacteria |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482032 For preventing various kinds of damage resulting from oxidation and exposure to ultraviolet light; for use in food, cosmetics and medicine |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | US7482000 Point mutations; immunology |
| 01/27/2009 | CA2389280C Triazoles as farnesyl transferase inhibitors |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2378803C Vitamin d3 analogs |
| 01/27/2009 | CA2360762C Sebocytes, sebocyte cell lines and applications thereof |
| 01/27/2009 | CA2296669C Nutritional composition for the treatment of pressure ulcers |
| 01/27/2009 | CA2294586C Homoserine lactones biofilm regulating compounds and their methods of use |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/22/2009 | WO2009011112A1 Stable fat emulsion containing prostaglandin e1 |
| 01/22/2009 | WO2009010687A2 Target enzyme in the treatment of acne |
| 01/22/2009 | WO2009010587A1 Use of at least one extract of the aerial portions of fireweed and/or evening primrose for preparing a composition for restoring the barrier function of keratinised or mucous tissues |
| 01/22/2009 | WO2009010491A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 01/22/2009 | WO2009010479A2 Heterocyclic methylene piperidine derivatives and their use |
| 01/22/2009 | WO2009010478A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 01/22/2009 | WO2009009935A1 Replication-deficient recombinant virus, pharmaceutical composition comprising the same and the uses thereof |
| 01/22/2009 | WO2009009818A1 Method of treating skin conditions with ovine amniotic fluid using iontophoresis |
| 01/22/2009 | WO2008138839A3 Preparation of cosmetic active principles by culturing vitreoscilla on thermal water and compositions comprising them |
| 01/22/2009 | US20090023900 Anti-AlphaVBeta3 Recombinant Human Antibodies, Nucleic Acids Encoding Same |
| 01/22/2009 | US20090023811 Biphenyl compound selective agonists of gamma RAR receptors |
| 01/22/2009 | US20090023793 Reducing pigmentation of skin for cosmetic effects by administering tyrosine hydroxylase inhibitors to prevent the biosynthesis of DOPA and catecholamines; thioacetanilide; hyperpigmentation-related medical conditions such as melasma, age spots, freckles, ochronosis, and lentigo |
| 01/22/2009 | US20090023792 reducing pigmentation of skin for cosmetic effects by administering tyrosine hydroxylase inhibitors to prevent the biosynthesis of DOPA and catecholamines; thioacetanilide; hyperpigmentation-related medical conditions such as melasma, age spots, freckles, ochronosis, and lentigo |
| 01/22/2009 | US20090023785 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/22/2009 | US20090023774 Pyridine analogs as C5A antagonists |
| 01/22/2009 | US20090023761 Heterocyclic compounds and their uses |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023722 Amide substituted imidazoquinolines |
| 01/22/2009 | US20090023715 Wound Healing |
| 01/22/2009 | US20090023681 Method of using beta-glucan from schizophyllum commune |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023663 Thymosin beta 4 compositions and methods |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023648 Methods for Treating Body Tissue |
| 01/22/2009 | US20090023646 GHRH analogues |
| 01/22/2009 | US20090023628 Cosmetic Composition and a Process for Preparing This Cosmetic Composition and a Cosmetic Product |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023216 Double-Stranded Oligonucleotides |
| 01/22/2009 | US20090022826 Multi-step method of pain and/or inflammation treatment |
| 01/22/2009 | US20090022819 Bacterial extracts cultured in thermal waters for the treatment of dry skin |
| 01/22/2009 | US20090022818 High-foaming, viscous cleanser composition with a skin care agent |
| 01/22/2009 | US20090022815 Halogenated composition, method for preparing same and uses thereof |
| 01/22/2009 | US20090022779 Phenytoin Formulations, and Uses Thereof in Wound Healing |
| 01/22/2009 | US20090022743 Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells |
| 01/22/2009 | US20090022733 Methods for treating Disease with an IL-1R antibody |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022712 Compositions and Methods for Inhibiting Leukocyte Function |
| 01/22/2009 | US20090022677 Methods for identifying treatments that treat and/or prevent UV irradiation induced photoaging |
| 01/22/2009 | DE102007033445A1 Diaphragmalyse-Verfahren und Verwendung der nach dem Verfahren erhaltenen Produkte Diaphragmalysis method and use of the products obtained by the process |
| 01/22/2009 | DE102007032662A1 Formulation for protecting skin aging caused by intrinsic or extrinsic factors, and for treating itching skin and atopic eczema, has apiogalacturonan or apiogalacturonan containing extract of Zostera marina and one or multiple hydrocolloids |
| 01/22/2009 | CA2696833A1 Disease treatment via antimicrobial peptides or their inhibitors |
| 01/22/2009 | CA2693887A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 01/22/2009 | CA2693153A1 Target enzyme in the treatment of acne |
| 01/21/2009 | EP2017262A1 Process for production of carotenoid |